How IGF-1 LR3 Works: Mechanism and Pharmacology
How IGF-1 LR3 works: its target and mechanism as the sources state them, how long it acts, and what is still unknown.
- Class
- IGF-1 analog
- FDA status
- Not approved
- research chemical
- Routes studied
- infusion by mini-osmotic pump; continuous infusion; infusion
- Half-life
- 563 min half-life in wound fluid (versus 872 min for IGF-I)
- wound chamber (rat), rat · The American journal of physiology 1999, PMID 10198302
How long it acts
Half-life values from FDA labels and published studies, by route. Animal values are labelled and do not describe people.
| Route | Half-life | Measured in | Source |
|---|---|---|---|
| wound chamber (rat) | 563 min half-life in wound fluid (versus 872 min for IGF-I) | Animal · rat | The American journal of physiology 1999, PMID 10198302 |
Why LR3 differs from native IGF-I
An LR3 study describes it as an IGF-1 analog with low affinity for IGF-binding proteins and high affinity for the IGF-1 receptor.[2]
A diabetic-rat study named the variant as having arginine at residue 3 and an N-terminal extension, and said such variants bind poorly to IGF-binding proteins.[3]
In rat wound fluid, LR3-IGF-I was cleared faster than IGF-I because it associated less with the binding proteins there.[1]
That wound-chamber study measured half-lives of 872 minutes for IGF-I and 563 minutes for LR3-IGF-I; this is rat data.[1]
What happens in animals
In the guinea pig, LR3IGF-I infusion reduced plasma IGF-I, IGF-II and IGF binding protein concentrations while organs grew.[4]
In finisher pigs, the authors proposed that suppressed plasma growth hormone may explain the fall in IGF-I, IGFBP-3 and insulin seen with LR3IGF-I.[5]
In fetal sheep, a 1-week LR3 infusion lowered insulin concentrations and glucose-stimulated insulin secretion.[2]
In rat intestine, LR3IGF-I induced proportional rises in thymidine labelling and crypt size, which the authors read as faster proliferative events than with the native peptide.[6]
What is not known in people
The 2 Oct 2026 PubMed search for IGF-1 LR3 with half-life, pharmacokinetic or clearance terms returned 2 papers, and none of the cached abstracts describes a human mechanism study.
Calculated from query ("LR3"[tiab] AND IGF[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab] OR clearance[tiab]); date 2026-10-02; count 2. Formula: count taken from the evidence file's search record
Related peptides
Common questions
How long does IGF-1 LR3 act in the body?
The half-life values we found are 563 min half-life in wound fluid (versus 872 min for IGF-I) (wound chamber (rat), rat). A half-life is how long the amount in the body takes to fall by half; it is not the same as how long an effect lasts.
How does IGF-1 LR3 work?
It is an IGF-1 analogue that binds the IGF-1 receptor with high affinity but binds IGF-binding proteins poorly.[2]
More on IGF-1 LR3
Sources
- 1Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions.The American journal of physiology · 1999PMID 10198302Accessed 2 Oct 2026
- 2IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep.American journal of physiology. Endocrinology and metabolism · 2025PMID 39679943Accessed 2 Oct 2026
- 3Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects.The Biochemical journal · 1993PMID 7683875Accessed 2 Oct 2026
- 4Long R3 insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig.The Journal of endocrinology · 1995PMID 7561636Accessed 2 Oct 2026
- 5Long [R3] insulin-like growth factor-I reduces growth, plasma growth hormone, IGF binding protein-3 and endogenous IGF-I concentrations in pigs.The Journal of endocrinology · 1997PMID 9488001Accessed 2 Oct 2026
- 6Administration of insulin-like growth factor-I (IGF-I) peptides for three days stimulates proliferation of the small intestinal epithelium in rats.Gut · 1995PMID 8549937Accessed 2 Oct 2026
Found an error? Report a correction.